STOCK TITAN

[SCHEDULE 13G] Bluejay Diagnostics, Inc. Passive Investment Disclosure (>5%)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Bluejay Diagnostics, Inc. Schedule 13G reports that three reporting persons — Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC — may be deemed to beneficially own 114,840 shares of common stock, representing 9.99% of the class based on 1,034,715 shares outstanding as of May 4, 2026. The filing states these shares are issuable upon exercise of a warrant held by Intracoastal and describes multiple additional warrant tranches that are subject to exercise restrictions and resale‑registration conditions.

Positive

  • None.

Negative

  • None.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





095633608

(CUSIP Number)
06/03/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Mitchell P. Kopin
Signature:/s/ Mitchell P. Kopin
Name/Title:Mitchell P. Kopin
Date:06/05/2026
Daniel B. Asher
Signature:/s/ Daniel B. Asher
Name/Title:Daniel B. Asher
Date:06/05/2026
Intracoastal Capital LLC
Signature:/s/ Mitchell P. Kopin
Name/Title:Mitchell P. Kopin, Manager
Date:06/05/2026
Exhibit Information

Exhibit 1 - Joint Filing Agreement